THE IMPACT OF ANXIETY ON HEALTHCARE UTILIZATION AND COSTS AMONG RESPONDENTS FROM THE CO-MORBIDITIES AND SYMPTOMS OF DEPRESSION (CODE) STUDY
Author(s)
Stephenson JJ1, Grabner M1, Faries D2, Palli SR3, Robinson R2
1HealthCore Inc., Wilmington, DE, USA, 2Eli Lilly, Indianapolis, IN, USA, 3CTI Clinical Trial & Consulting, Cincinnati, OH, USA
OBJECTIVES: To assess the impact of anxiety and of the depression-anxiety interaction on healthcare utilization and costs among patients with depression. METHODS: Survey-eligible adults with ≥2 medical claims for depression from 6/1/2009-5/31/2010 in the HealthCore Integrated Research Database were invited to participate in this retrospective/prospective study. Consenting respondents completed index and 6-month surveys assessing health measures. Significant anxiety was classified into 4 categories (persistently anxiety free, persistent anxiety, resolving anxiety, and emerging anxiety) based on Generalized Anxiety Disorder (GAD-7) scores at both surveys. Respondents’ survey data were linked to 24-months of claims data (+12 months from index survey date). Mean annual post-index costs were compared using non-parametric bootstrapping adjusting for initial differences in demographics and health status using propensity score stratification. Similar models were created adding the interaction of remission status. RESULTS: Of 910 respondents with both surveys, 79.3% were female and mean (SD) age was 47.6 (11.4) years. Most respondents were persistently anxiety free (52.9%), followed by persistent anxiety (23.4%), resolving anxiety (15.1%), and emerging anxiety (8.7%). Higher post-index all-cause healthcare costs were observed in respondents with persistent anxiety compared to others (combined group of resolving, emerging, or persistently anxiety-free) ($15,027 [$1,838] vs. $11,311 [$680], p=.0018). Persistent anxiety respondents had significantly higher mental health-related costs than persistently anxiety free respondents ($4,226 [$551] vs. $3,044 [$332], p<.001). Respondents with anxiety and non-remitted depression had significantly higher all-cause and mental-health related costs vs. respondents without anxiety and non-remitted depression, with mean differences of $2,480 (95% CI: $337 to $4,685, p<.0001) and $789 (95% CI: $146 to $1,428, p<.0001), respectively. CONCLUSIONS: Respondents with a history of depression and persistent anxiety continue to have increased healthcare costs. Anxiety was a key factor irrespective of whether depression resolved. This study emphasizes the importance of treating patients to full resolution of all symptoms.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PMH28
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Mental Health